Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized 3-way crossover pharmacokinetic study of flurbiprofen transdermal formulations versus Yakuban Tape in healthy adults
NL-OMON40944Active, not recruiting
- Sponsor
- Noven Pharmaceuticals
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of flurbiprofen in inflammation, rheumatoid arthritis (RA) and musculoskeletal condition (MSK) (3 arms), sponsored by Noven Pharmaceuticals. Primary endpoint: Pharmacokinetic profile of flurbiprofen after two FTS formulations. Started May 2014; status: active, not recruiting.
02
Drugs
flurbiprofen
03
Conditions
inflammationrheumatoid arthritis (RA)musculoskeletal condition (MSK)
Beyond the preview
Go deeper on NL-OMON40944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40944.